These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 2643933)

  • 21. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
    Noyes R; Garvey MJ; Cook BL; Samuelson L
    J Clin Psychiatry; 1989 May; 50(5):163-9. PubMed ID: 2715139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine in the treatment of panic disorder and its complications.
    Liebowitz MR
    Psychiatr Clin North Am; 1985 Mar; 8(1):37-47. PubMed ID: 3887338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
    Noyes R; Garvey MJ; Cook BL
    J Affect Disord; 1989; 16(2-3):249-57. PubMed ID: 2522124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological response to stress in agoraphobia and panic attacks.
    Surman OS; Williams J; Sheehan DV; Strom TB; Jones KJ; Coleman J
    Biol Psychiatry; 1986 Jul; 21(8-9):768-74. PubMed ID: 3524696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.
    Cassano GB; Petracca A; Perugi G; Nisita C; Musetti L; Mengali F; McNair DM
    J Affect Disord; 1988; 14(2):123-7. PubMed ID: 2966825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
    Mavissakalian M; Michelson L; Dealy RS
    Br J Psychiatry; 1983 Oct; 143():348-55. PubMed ID: 6626853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA; Tesar GE; Rosenbaum JF; Woods SW
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipramine treatment of panic disorder with agoraphobia: the second time around.
    Mavissakalian MR; Perel JM; de Groot C
    J Psychiatr Res; 1993; 27(1):61-8. PubMed ID: 8515390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
    Pohl R; Balon R; Yeragani VK; Gershon S
    Psychopathology; 1989; 22 Suppl 1():60-7. PubMed ID: 2657839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC; Burrows GD; DuPont RL; Lesser IM; Noyes R; Pecknold JC; Rifkin A; Swinson RP
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomic changes after treatment of agoraphobia with panic attacks.
    Roth WT; Telch MJ; Taylor CB; Agras WS
    Psychiatry Res; 1988 Apr; 24(1):95-107. PubMed ID: 3393620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M; Lecrubier Y; Maier W; Buller R; Rosenberg R; Hippius H
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of panic disorder with imipramine alone.
    Garakani H; Zitrin CM; Klein DF
    Am J Psychiatry; 1984 Mar; 141(3):446-8. PubMed ID: 6367495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.